Search Results - "Chooback, N"
-
1
ALK inhibitors, resistance development, clinical trials
Published in Current oncology (Toronto) (01-06-2018)“…The treatment of advanced non-small-cell lung cancer (nsclc) has undergone a paradigm shift since the early 2000s. The identification of molecular subtypes of…”
Get full text
Journal Article -
2
Carcinoma ex pleomorphic adenoma: case report and options for systemic therapy
Published in Current oncology (Toronto) (01-06-2017)“…The most common benign salivary tumour is a pleomorphic adenoma. Transformation to malignancy, carcinoma ex pleomorphic adenoma (cxpa), occurs in 6% of cases…”
Get full text
Journal Article -
3
Population-Based Analysis of Outcomes for Patients With Brain Metastases From Epidermal Growth Factor Receptor Mutation Positive Non-Small Cell Lung Cancer Treated With Tyrosine Kinase Inhibitor Alone or Combined With Radiotherapy
Published in International journal of radiation oncology, biology, physics (01-11-2021)“…With modern therapies, the median survival of patients with brain metastases (BrM) from non-small cell lung cancer (NSCLC) with epidermal growth factor…”
Get full text
Journal Article -
4
Outcome Differences Between First- and Second-generation EGFR Inhibitors in Advanced EGFR Mutated NSCLC in a Large Population-based Cohort
Published in Clinical lung cancer (01-09-2019)“…Second-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) appear superior to first-generation TKIs in clinical trials, but at…”
Get full text
Journal Article -
5
Canadian Lung Cancer Conference 2017
Published in Current oncology (Toronto) (01-08-2017)“…The 2017 Canadian Lung Cancer Conference was held 9–10 February in Vancouver, British Columbia. Each year at this prestigious event, hundreds of professionals…”
Get full text
Journal Article -
6
Development of a web-based application using machine learning algorithms to facilitate systematic literature reviews
Published in Annals of oncology (01-09-2017)Get full text
Journal Article